Amgen Makes History with $762M Off-Label Settlement
In what's being called the largest settlement ever for a biotech company, Amgen Inc. finalized a $612 million agreement Tuesday to resolve federal civil claims stemming from 10 whistleblower suits alleging off-label marketing of several of its top-selling drugs.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter